Methods of preparing substituted tetracyclines with transition metal-based chemistries
View Patent ↗The present invention relates to novel chemistries which allow for heretofore unobtainable substituted tetracycline compounds which exhibit significant activity in tetracycline responsive states. The methods disclosed herein utilize reactive tetracycline-based precursor compounds, reactive organic substituent precursors and transition metal catalysts under conditions such that a tetracycline compound substituted with the desired organic substituent is formed. In one embodiment of the invention, a substituted tetracycline compound may be prepared by combining a reactive tetracycline-based precursor compound such as an arene tetracycline diazonium salt, and a reactive organic substituent precursor, e.g., alkenes, substituted alkenes, vinyl monomers, aromatics and heteroaromatics, in the presence of a transition metal catalyst, such as palladium chloride, under conditions such that a tetracycline compound substituted with the organic substituent is formed. Such compounds may optionally act as intermediates for making other compounds, e.g., hydrogenation of unsaturated groups on the substituent.
1. A 9-substituted tetracycline compound, wherein the substituent at the 9 position is connected with a —C—C— linkage and comprises a carbonyl moiety selected from the group consisting of a diketone, an anhydride, a hydrazone, and an imide.
2. A substituted tetracycline compound, wherein the substituent comprises a carbonyl moiety selected from the group consisting of a diketone, an anhydride, a hydrazone, and an imide, made by a method comprising contacting a reactive tetracycline chemical complex comprising a reactive tetracycline-based precursor compound and a transition metal catalyst; forming a reactive chemical intermediate with a reactive organic substituent precursor under appropriate conditions, such that a substituted tetracycline compound is formed, wherein said carbonyl moiety is connected with a —C—C— linkage to said tetracycline compound.
3. The substituted tetracycline compound of claim 2 , wherein said transition metal catalyst comprises rhodium, iron, iridium, chromium, zirconium, nickel, copper, palladium or mixtures thereof.
4. The substituted tetracycline compound of claim 3 , wherein said transition metal catalyst comprises palladium acetate, Pd(PPh 3 ) 4 , Pd(AsPh 3 ) 4 , PdCl 2 (PhCN) 2 , PdCl 2 (Ph 3 P) 2 , Pd 2 (dba) 3 -CHCl 3 or combinations thereof.
5. The substituted tetracycline compound of claim 2 , wherein said reactive tetracycline-based precursor compound is selected from the group consisting of oxytetracycline, chlortetracycline, demeclocycline, doxycycline, chelocardin, minocycline, rolitetracycline, lymecycline, sancycline, methacycline, apicycline, clomocycline, guamecycline, meglucycline, mepylcycline, penimepicycline, pipacycline, etamocycline, penimocycline arenediazonium salts, iodo derivatized tetracycline compounds and boronic acid derivatized tetracycline compounds.
6. The substituted tetracycline compound of claim 5 , wherein said reactive tetracycline-based precursor compound is selected from the group consisting of reactive minocycline-based precursor compounds, reactive doxycycline-based precursor compounds and reactive sancycline-based precursor compounds.
7. The substituted tetracycline compound of claim 2 , wherein said reactive organic substituent precursor is carbon monoxide.
8. The substituted tetracycline compound of claim 2 or 7 , wherein said method further comprises contacting the reactive chemical intermediate with an additional reactive organic substituent precursor selected from the group consisting of an anhydride precursor, a hydrazone precursor, and an imide precursor.
9. The substituted tetracycline of claim 2 , wherein said substituted tetracycline compound is substituted at the 9 position.
10. A 9-substituted tetracycline compound, wherein the substituent at the 9 position is connected with a —C—C— linkage and comprises a ketone.
11. A substituted tetracycline compound, wherein the substituent comprises a ketone, made by a method comprising contacting a reactive tetracycline chemical complex comprising a reactive tetracycline-based precursor compound and a transition metal catalyst; and forming a reactive chemical intermediate with a reactive organic substituent precursor under appropriate conditions, such that a substituted tetracycline compound is formed, wherein said ketone is connected with a —C—C— linkage to said tetracycline compound.
12. The substituted tetracycline compound of claim 11 , wherein said transition metal catalyst comprises rhodium, iron, iridium, chromium, zirconium, nickel, copper, palladium or mixtures thereof.
13. The substituted tetracycline compound of claim 12 , wherein said transition metal catalyst comprises palladium acetate, Pd(PPh 3 ) 4 , Pd(AsPh 3 ) 4 , PdCl 2 (PhCN) 2 , PdCl 2 (Ph 3 P) 2 , Pd 2 (dba) 3 -CHCl 3 or combinations thereof.
14. The substituted tetracycline compound of claim 11 , wherein said reactive tetracycline-based precursor compound is selected from the group consisting of oxytetracycline, chlortetracycline, demeclocycline, doxycycline, chelocardin, minocycline, rolitetracycline, lymecycline, sancycline, methacycline, apicycline, clomocycline, guamecycline, meglucycline, mepylcycline, penimepicycline, pipacycline, etamocycline, penimocycline arenediazonium salts, iodo derivatized tetracycline compounds and boronic acid derivatized tetracycline compounds.
15. The substituted tetracycline compound of claim 14 , wherein said reactive tetracycline-based precursor compound is selected from the group consisting of reactive minocycline-based precursor compounds, reactive doxycycline-based precursor compounds and reactive sancycline-based precursor compounds.
16. The substituted tetracycline compound of claim 11 , wherein said reactive organic substituent precursor is carbon monoxide.
17. The substituted tetracycline compound of claim 11 or 16 , wherein said method further comprises contacting the reactive chemical intermediate with a ketone precursor.
18. The substituted tetracycline of claim 11 , wherein said substituted tetracycline compound is substituted at the 9 position.